Empresa CSL Limited

Empresa CSL Limited

CSL

AU000000CSL8

Farmacéuticos

Consenso de los analistas

Acciones

CSL

AU000000CSL8

Farmacéuticos

Consenso de los analistas

Resumen de negocios

Ventas por actividad

Ventas por región

Directores

Administradores

Clase de acciones

Accionistas

Participaciones

Información de la empresa

Empresas del grupo

Sector

Ventas por actividad

Ventas por región

Notaciones para CSL Limited

Revisiones del BPA

Beneficios trimestrales - Tasa de sorpresa

Sector Biofármacos

Resumen de negocios

Ventas por actividad

Ventas por región

Directores

Administradores

Clase de acciones

Accionistas

Participaciones

Información de la empresa

Empresas del grupo

Sector

Ventas por actividad

Ventas por región

Notaciones para CSL Limited

Revisiones del BPA

Beneficios trimestrales - Tasa de sorpresa

Sector Biofármacos

Diferido Australian S.E. Otros sitios de cotización 08:10:52 24/04/2024			Varia. Cinco días.	Varia. 1 de enero.
278,4 ^AUD	-0,19 %		+2,14 %	-2,86 %

24/04	CSL Vifor y Travere Therapeutics anuncian que la Comisión Europea aprueba FILSPARI® (esparsentán) para el tratamiento de la Nefropatía IgA	CI
24/04	Las acciones australianas suben impulsadas por los bancos y la energía; el IPC del trimestre de marzo en el punto de mira	RE

CSL Limited es una empresa biotecnológica con sede en Australia. Las áreas de interés de la empresa incluyen las enfermedades raras y graves, las vacunas contra la gripe y la deficiencia de hierro y nefrología. Los segmentos de la empresa incluyen CSL Behring, CSL Seqirus y CSL Vifor. El segmento CSL Behring fabrica, comercializa y distribuye hemoderivados, terapias génicas y recombinantes. El segmento CSL Seqirus fabrica, comercializa y distribuye predominantemente productos relacionados con la gripe y presta servicios para pandemias a los gobiernos. El segmento CSL Vifor fabrica, comercializa y distribuye productos en las áreas terapéuticas de la deficiencia de hierro y la nefrología. Su CSL Plasma gestiona redes de obtención de plasma, con más de 325 centros de obtención de plasma en Estados Unidos, Europa y China. La empresa opera en Australia, Estados Unidos, Alemania, Reino Unido, Suiza y China. Sus productos incluyen Respreeza, Zemaira, HAEGARDA, KCENTRA, Hepatitis B, Evogam y otros.

Número de empleados: 32 065

AUD en millones	2022	Peso	2023	Peso	Delta
CSL Behring 69,8 %	11 857	81,4 %	13 811	69,8 %	+16,48 %
CSL Seqirus 15,3 %	2 708	18,6 %	3 019	15,3 %	+11,52 %
CSL Vifor 14,9 %	-	-	2 957	14,9 %	-

AUD en millones	2022	Peso	2023	Peso	Delta
United States 49,3 %	7 065	48,5 %	9 757	49,3 %	+38,10 %
Rest of World 21,4 %	2 776	19,1 %	4 236	21,4 %	+52,59 %
Australia 7,9 %	1 409	9,7 %	1 554	7,9 %	+10,23 %
Germany 6,5 %	1 077	7,4 %	1 292	6,5 %	+19,93 %
China 5,9 %	1 027	7,0 %	1 158	5,9 %	+12,79 %
United Kingdom 5,4 %	822	5,6 %	1 066	5,4 %	+29,68 %
Switzerland 3,7 %	388	2,7 %	725	3,7 %	+86,90 %

Directores	Puesto	Edad	Desde
Paul McKenzie CEO	Chief Executive Officer	58	01/06/19
Joy Carolyn Linton DFI	Director of Finance/CFO	59	01/10/20
Mark Hill CTO	Chief Tech/Sci/R&D Officer	62	01/10/20
William Mezzanotte CTO	Chief Tech/Sci/R&D Officer	66	01/10/18
Andrew Nash CTO	Chief Tech/Sci/R&D Officer	-	01/11/06
Andrew Cuthbertson BRD	Director/Board Member	70	01/03/97
Mark Dehring IRC	Investor Relations Contact	-	-
Kate Priestman PRN	Corporate Officer/Principal	-	11/09/23
Ken Lim PRN	Corporate Officer/Principal	50	01/01/13
Bill Campbell PRN	Corporate Officer/Principal	64	01/01/14

Administradores	Puesto	Edad	Desde
Carolyn Hewson BRD	Director/Board Member	69	09/12/19
Brian McNamee PSD	President	68	01/07/90
Alison Watkins BRD	Director/Board Member	61	19/08/21
Andrew Cuthbertson BRD	Director/Board Member	70	01/03/97
Megan Clark BRD	Director/Board Member	66	16/02/16
Marie McDonald BRD	Director/Board Member	68	14/08/13
Sam Lewis BRD	Director/Board Member	-	01/01
Duncan Maskell BRD	Director/Board Member	63	18/08/21
Paul McKenzie CEO	Chief Executive Officer	58	01/06/19

	Vote	Quantity	Flotante	Autocontrol	Total Float
Acción A	1	483 093 257	480 846 726 ( 99,53 %)	0	99,53 %

Nombre	Acciones	%	Valoración
State Street Global Advisors Trust Co. 1,107 %	5 349 487	1,107 %	1 005 M $
Colonial First State Investments Ltd. 0,9797 %	4 734 581	0,9797 %	889 M $
Commonwealth Superannuation Corp. (Investment Management) 0,6784 %	3 278 217	0,6784 %	616 M $
Netwealth Investments Ltd. 0,5316 %	2 568 812	0,5316 %	483 M $
Australian Foundation Investment Co. Ltd. (Invt Mgmt) 0,5030 %	2 431 000	0,5030 %	457 M $
BetaShares Capital Ltd. 0,3329 %	1 608 787	0,3329 %	302 M $
AMP Capital Investors Ltd. 0,2738 %	1 322 973	0,2738 %	249 M $
Argo Investments Ltd. (Investment Management) 0,2594 %	1 253 509	0,2594 %	235 M $
State Street Global Advisors Ltd. 0,2178 %	1 052 335	0,2178 %	198 M $
Australian Eagle Asset Management Pty Ltd. 0,2019 %	975 763	0,2019 %	183 M $

Nombre	Acciones	%	Valoración
SILVERCREST ASSET MANAGEMENT GROUP INC. 0,006264 %	60 545	0,006264 %	6 M $
Boston Common Asset Management LLC 0,004533 %	43 811	0,004533 %	4 M $
Domini Impact Investments LLC 0,003321 %	32 100	0,003321 %	3 M $
Yousif Capital Management LLC 0,001762 %	17 030	0,001762 %	2 M $
RhumbLine Advisers LP 0,001472 %	14 227	0,001472 %	1 M $
Budapest Fund Management Co. Ltd. 0,000507 %	4 901	0,000507 %	460 302 $
SVB Wealth LLC 0,000405 %	3 919	0,000405 %	368 072 $
GAMMA Investing LLC 0,000171 %	1 652	0,000171 %	155 156 $
Ametos Invest GmbH 0,000124 %	1 200	0,000124 %	112 704 $
PNC Investments LLC 0,000017 %	161	0,000017 %	15 121 $

Nombre	Acciones	%	Valoración
CARA THERAPEUTICS, INC. 13.53%	7 396 770	13.53%	6 731 061 $

CSL Ltd.

655 Elizabeth Street

3000, Melbourne

+61 3 9389 1911

http://www.csl.com.au

Nombre	Categoría y sector
CSL Behring LLC CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA.	Biotechnology
CSL Behring AG CSL Behring AG BiotechnologyHealth Technology Part of CSL Ltd., CSL Behring AG is a Swiss company that develops biological products. The private company is based in Bern, Switzerland.	Biotechnology
CSL Behring UK Ltd. CSL Behring UK Ltd. Pharmaceuticals: MajorHealth Technology Part of CSL Ltd., CSL Behring UK Ltd. is a private company that manufactures and supplies plasma therapies. The company is based in Haywards Heath, UK. The British company was founded in 1916 by Emil von Behring.	Pharmaceuticals: Major
CSL Behring GmbH CSL Behring GmbH Pharmaceuticals: MajorHealth Technology Part of CSL Ltd., CSL Behring GmbH is a German company that actively collaborates to develop special programs and activities for patients with rare diseases. The private company is based in Marburg, Germany. The CEOs of the company are Lutz Guenter Bonacker, Michael Schröder, Craig Shelanskey.	Pharmaceuticals: Major
CSL Behring Beteiligungs- und Verwaltungs GmbH & Co. KG CSL Behring Beteiligungs- und Verwaltungs GmbH & Co. KG Pharmaceuticals: MajorHealth Technology Part of CSL Ltd., CSL Behring Beteiligungs- und Verwaltungs GmbH & Co. KG is a German pharmaceutical company that manufactures pharmaceutical products. The private company is based in Marburg, Germany. The company was founded in 2004. The CEO is Craig Shelanskey.	Pharmaceuticals: Major
CSL Plasma GmbH CSL Plasma GmbH Medical/Nursing ServicesHealth Services CSL Plasma GmbH provides plasma collection and donation services. It specializes in the collection, testing, and management of plasma taken from blood donors. It focuses on the use of plasma as a key ingredient for products crucial to treating patients suffering from hemophilia, shock or trauma, immune deficiencies, and other blood disorders. It operates through its testing laboratories, collection facilities, and logistics centers. The company is headquartered in Marburg, Germany.	Medical/Nursing Services
CSL Finance GmbH CSL Finance GmbH Financial ConglomeratesFinance Part of CSL Ltd., CSL Finance GmbH is a German company that provides investment services. The company is based in Marburg, Germany. The CEOs are Antje Michel, Dieter Engstfeld, John Andrew Goodman Levy. The private company was founded in 2014.	Financial Conglomerates
CSL Behring Recombinant Facility AG CSL Behring Recombinant Facility AG BiotechnologyHealth Technology Part of CSL Ltd., CSL Behring Recombinant Facility AG is a Swiss biotherapeutics company that develops and delivers innovative therapies to improve patients' lives. The private company is based in Bern, Switzerland and has a manufacturing site there. The company's portfolio includes a wide range of recombinant and plasma-derived products.	Biotechnology
CSL Behring Lengnau AG

Calificación trading

Calificación Inversor

ESG Refinitiv

A-

Más Ratings

Venta

Compra

Recomendación promedio

ACUMULAR

Numero de análisis

Último precio de cierre

180,7 USD

Precio objetivo promedio

199,4 USD

Diferencia / Objetivo Promedio

+10,36 %

Consenso

Revisiones de las previsiones

La agenda de la empresa

	Varia. 1 de ene.	Capi.
CSL LIMITED	-2,86 %	87,37 mil M
SAMSUNG BIOLOGICS CO.,LTD.	+3,95 %	41,01 mil M
BIOGEN INC.	-21,94 %	28,08 mil M
UCB	+53,11 %	24,72 mil M
BIOMARIN PHARMACEUTICAL INC.	-5,41 %	17,47 mil M
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-44,23 %	11,69 mil M
INCYTE CORPORATION	-17,60 %	11,6 mil M
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-13,96 %	11,56 mil M
SWEDISH ORPHAN BIOVITRUM AB	-0,22 %	8443,21 M
INTRA-CELLULAR THERAPIES, INC.	+2,09 %	7721,25 M

Biofármacos

Farmacéutica e investigación médica

Farmacéuticos

Farmacéuticos

Biofármacos